TVTX
Travere Therapeutics, Inc.
$42.60
-0.14%
2026-05-08
About Travere Therapeutics, Inc.
Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States. The company's products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II); and Thiola and Thiola EC (tiopronin tablets) for the treatment of cystinuria, a rare genetic cystine transport disorder that causes high cystine levels in the urine and the formation of recurring kidney stones. Its clinical-stage programs consist of Sparsentan, a novel investigational product candidate, which has been granted Orphan Drug Designation for the treatment of focal segmental glomerulosclerosis in the U.S. and Europe; and Pegtibatinase, a novel investigational human enzyme replacement candidate being evaluated for the treatment of classical homocystinuria. It has a collaboration agreement with PharmaKrysto Limited for the pre-clinical activities associated with the cystinuria program. Travere Therapeutics, Inc. was formerly known as Retrophin, Inc. and changed its name to Travere Therapeutics, Inc. in November 2020. The company is headquartered in San Diego, California.
Key Fundamentals
Forward P/E
8.54
EPS (TTM)
$-0.50
ROE
-69.4%
Revenue Growth (YoY)
55.6%
Profit Margin
-4.0%
Debt/Equity
331.88
Price/Book
33.85
Beta
1.14
Market Cap
$3.98B
Avg Volume (10D)
2.9M
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$48.60
60D Low
$26.15
Avg Volume
2.0M
Latest Close
$42.60
Get breakout alerts for TVTX
Sign up for Breakout Scanner to receive daily notifications when TVTX triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Travere Therapeutics, Inc. (TVTX) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors TVTX daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. TVTX operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.